top of page
Doctor with xray in his hands showing structure of knee joint on artificial model closeup.
Vår expertis
Leading in Patents & Innovation

Artroa is a trailblazer in innovation, holding numerous patents for cutting-edge technologies that have revolutionized the diagnosis and treatment of osteoarthritis. These patents are a testament to the company´s commitment to pushing the boundaries of what is possible in the fight against this debilitating condition.

Early Diagnosis through Biomarkers:

Artroa´s groundbreaking research has led to the identification of specific biomarkers that enable the
early detection of osteoarthritis. Through advanced molecular analysis and biomarker identification,
Artroa´s diagnostic tools can pinpoint the presence of osteoarthritis in its nascent stages. This early
diagnosis empowers veterinarians to intervene proactively, potentially halting the progression of the
disease before it causes significant damage.

A Novel Disease-Modifying Drug

:Central to Artroa´s contributions is the development of a groundbreaking disease-modifying drug. This pharmaceutical marvel represents a paradigm shift in osteoarthritis treatment. By targeting the underlying mechanisms of the disease (healing the cells), this novel drug not only alleviates symptoms (lameness) but also actively slowing down the progression of osteoarthritis. Artroa´s drug offers newfound hope to horses, promising a  future where osteoarthritis can be not just managed but effectively halted in its tracks.

Individual Approach

Artroa´s approach is deeply individual-centric. By focusing on early diagnosis and offering a disease-modifying drug, Artroa ensures that horses receive timely, personalized, and effective care

Vill du ha mer information om Artroa?

Kontakta oss här


bottom of page